13. Radiosurgery in ocular disorders: clinical applications

Progress in Neurological Surgery

Volumn 20, Issue , 2007, Pages 324-339

  Liscak R ^a   Vladyka, V ^a  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY POSTURE; EYE DISEASE; GLAUCOMA; HUMAN; IMAGE QUALITY; INSTRUMENTATION; MELANOMA; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOSURGERY; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; UVEA TUMOR;

ADULT; AGED; EYE DISEASES; GLAUCOMA; HUMANS; MACULAR DEGENERATION; MAGNETIC RESONANCE IMAGING; MELANOMA; PHANTOMS, IMAGING; PRONE POSITION; RADIOSURGERY; RETROSPECTIVE STUDIES; UVEAL NEOPLASMS;

EID: 34447512824     PISSN: 00796492     EISSN: 16623924     Source Type: Book Series    
DOI: 10.1159/000100176     Document Type: Article

References (53)

1. Marchini G, Gerosa M, Piovan E, et al: Gamma Knife stereotactic radiosurgery for uveal melanoma: Clinical results after 2 years. Stereotact Funct Neurosurg 1996;66(SUPPL1):208-213.
2. Pochop P, Pilbauer J, Krepelková J, Vladyka V, Lišcák R, Šimonová G: Two years of experience with therapy of uveal melanoma by using the Leksell gamma knife (in Czech). Cs Oftal 1998;54: 232-235.
3. Rand RW, Khonsary A, Brown WJ, et al: Leksell stereotactic radiosurgery in the treatment of eye melanoma. Neurol Res 1987;9:142-146.
4. Rennie I, Forster D, Kemeny A, Walton L, Kunkler I: The use of single fraction Leksell stereotactic radiosurgery in the treatment of uveal melanoma. Acta Ophthalmol Scand 1996;74:558-562.
5. Šimonová G, Novotný J. Jr, Lišcák R, Pilbauer J: Leksell gamma knife treatment of uveal melanoma. J Neurosurg 2002;97(SUPPL5):635-639.
6. Zehetmayer M, Kitz K, Menapace R, et al: Local tumor control and morbidity after one to three fractions stereotactic external beam irradiation for uveal melanoma. Radiother Oncol 2000;55: 135-144.
7. Novotný Jr. J, Novotný J, Vymazal J, Lišcák R, Vladyka V: Assessment of the accuracy of stereotactic target localization using magnetic resonance imaging: A phantom study. J Radiosurg 1998;1: 99-111.
8. Novotný Jr J, Dvorák P, Spevácek V, et al: Quality control of the stereotactic radiosurgery procedure with the polymer-gel dosimetry. Radiother Oncol 2002;63:223-230.
9. Novotný Jr J, Spevácek V, Hrbácek J, et al: Measurement of relative dose distributions in stereotactic radiosurgery by the polymer-gel dosimeter; in Kondziolka D (ed): Radiosurgery. Basel, Karger, 2004, vol 5, pp 225-235.
10. Brady LW, Markoe AM, Amendola BE, et al: The treatment of primary intraocular malignancy. Int J Radiat Oncol Biol Phys 1988;15:1355-1361.
11. Castro JR, Char D, Opetti P, et al: 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 1997;39:989-996.
12. Char DH, Quivey JM, Castro JR, et al: Helium ion versus iodine-125 brachytherapy in the management of uveal melanoma. Arch Ophthalmol 1990;108:209-214.
13. Char DH, Kroll S, Quivey J, et al: Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy. Br J Ophthalmol 1996;80:117-124.
14. Char DH, Castro JR, Kroll SM, et al: Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990;108:209-214.
15. Char DH, Kroll SM, Castro J: Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophtalmol 1998;125:81-89.
16. Courdi A, Caujolle JP, Grange JD, et al: Results of proton therapy of uveal melanoma treated in Nice. Int J Radiat Oncol Biol Phys 1999;45:5-11.
17. Damato BE, Paul J, Foulds WS: Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol 1996;80:102-108.
18. Dieckmann K, Bogner J, Georg D, Zehetmayer M, Kren G, Potter R: A linac-based stereotactic irradiation technique of uveal melanoma. Radiother Oncol 2001;61:49-56.
19. Egan KM, Gragoudas ES, Seddon JM, et al: The risk of enucleation after proton beam irradiation for uveal melanoma. Ophthalmology 1989;96:1377-1383.
20. Gragoudas ES, Egan KM, Walsh SM, et al: Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992;99:760-766.
21. Gradoudas ES, Seddon JM, Egan K, et al: Long-term results of proton beam irradiated uveal melanomas. Arch Ophthalmol 1987;94:349-353.
22. Gragoudas ES, Lane AM, Regan S, et al: A randomized controlled trial of varying radiation doses in the treatment of chorioidal melanoma. Arch Ophthalmol 2000;118:773-778.
23. Petrovich Z, Luxton G, Langohlz B, et al: Episcleral plaque radiotherapy in the treatment of uveal melanomas. Int J Radiat Oncol Biol Phys 1992;24:247-251.
24. Saunders WM, Char DH, Quivey JM, et al: Precision, high dose radiotherapy: Helium ion treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 1985;11:227-233.
25. Seregard S, aft Trampe E, Lax I, Kock E, Lundell G: Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma. Acta Ophtlamol Scand 1997;75:11-16.
26. Shields CL, Shields JA, Karlsson U, et al: Enucleation after plaque radiotherapy for posterior uveal melanoma. Ophthalmology 1990;97:1665-1670.
27. Tokuuye K, Aknine Z, Sumi M, et al: Fractionated stereotactic radiotherapy for chorioideal melanoma. Radiother Oncol 1997;43:87-91.
28. Wilson MW, Hungerford JL: Comparison of episcleral plaque and proton beam radiation therapy for the treatment of chorioidal melanoma. Ophthalmology 1999;106:1579-1587.
29. LENT SOMA Tables. Radiother Oncol 1995;35:25-26.
30. Alfonso A: Relationship of structural and functional measurements; in Weinreb RN, Kitazawa Y, Kriegelstein GK (eds): Glaucoma in the 21st Century. London, Mosby International Ltd., 2000, pp 57-65.
31. Fuchs HJ, Nissen KR, Goldschmidt E: Glaucoma blindness in Denmark. Acta Ophtalmol 1992;70: 73-78.
32. Harwerth RS, Carter-Dawson L, Shen F, Smith EL, Crawford ML: Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophtalmol Vis Sci 1999;40: 2242-2250.
33. Langham ME, Farrel R, Krakau T, Silver D: Ocular pulsatile blood flow, hypotensive drugs, and differential light sensitivity in glaucoma; in Krieglstein GK (ed): Glaucoma Update IV. Berlin, Springer-Verlag, 1991, pp 162-172.
34. Goldberg I: How common is glaucoma worldwide? in Weinreb RN, Kitazawa Y, Kriegelstein GK (eds): Glaucoma in the 21st Century. London, Mosby International Ltd., 2000, pp 3-8.
35. Pilbauer J, Hejduková I, Pašta J,Vladyka V, Lišcák R, Šimonová G: Our experience with treatment of some ocular vascular diseases by using the Leksell Gamma Knife (in Czech). Cs Oftal 1998;54: 235-241.
36. Pilbauer J, Hejduková I, Nemec P, Lišcák R, Vladyka V: Treatment of advanced glaucomas using Leksell Gamma Knife - A pilot clinical study. J Radiosurg 2000;3:155-158.
37. Vladyka V, Lišcák R, Šubrt O, et al: Initial experience with gamma knife radiosurgery for advanced glaucoma. J Neurosurg 2000;93:180-183.
38. Brigatti L, Caprioli J: Correlation of visual field with scanning confocal laser optic disc measurements in glaucoma. Arch Ophthalmol 1995;113:1191-1194.
39. Burk RO, Rohnrschneider K, Takamoto T, et al: Laser scanning tomography and stereophotogrammetry in three-dimensional optic disc analysis. Graefe's Arch Clin Exp Ophthalmol 1993;231: 193-198
40. Cauchan BC, Blanchard JW, Hamilton DC: Technique for detecting serial topographic changes in the optic disc and peripapillary retina using scanning laser tomography. Invest Ophthalmol Vis Sci 2000;41:775-782.
41. Greenfield DS: Optic nerve and retinal nerve fiber layer analyzers in glaucoma. Curr Opin Ophthalmol 2002;13:68-76.
42. Mardin CY, Junemann AG: The diagnostic value of optic nerve imaging in early glaucoma. Curr Opin Ophthalmol 2001;12:100-104.
43. Bergink GJ, Deutman AF, van den Broek JF: Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study. Graefes Arch Clin Exp Ophthalmol 1994;232:591-598.
44. Bergink GJ, Deutman AF, van den Broek JE, et al: Radiation therapy for age-related subfoveal choroidal neovascular membranes. A pilot study. Doc Ophthalmol 1995;90:67-74.
45. Berkow JW, Flower RW, Orth DH, Kelley JS: Fluorescein and Indocyanine Green Angiography, ed 2. San Francisco, American Academy of Ophthalmology, 1997, p 7.
46. Berson AM, Finger PT, Sherr DL: Radiotherapy for age-related macular degeneration: Preliminary results of a potentially new treatment. Int J Radiat Oncol Biol Phys 1996;36:861-865.
47. Finger PT, Berson A, Sherr D, et al: Radiation therapy for subretinal neovascularisation. Ophthalmology 1996;103:878-889.
48. Finger PT, Berson A, Ng T: Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127:170-177.
49. Weinberger AW, Wolf S, Kube T: Radiation therapy of occult choroidal neovascularisation (CNV) in age-related macular degeneration (AMD). Klin Monatsbl Augenheilkd 1999;214:96-99.
50. Archer DB, Amoaku WM, Gardiner TA: Radiation retinopathy-clinical, histopathological, ultrastructural and experimental correlations. Eye 1991;5:239-251.
51. Chakravarthy U, Houston RF, Archer DB: Treatment of age-related subfoveal neovascular membranes by teletherapy: A pilot study. Br J Ophthalmol 1993;77:265-273.
52. Haas A, Papaefthymiou G, Langmann G: Gamma knife treatment of subfoveal, classic neovascularization in age-related macular degeneration: A pilot study. J Neurosurg 2000;93(SUPPL3): 172-176.
53. Spaide RF, Guyer DR, McCormick B, et al: External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998;105:24-30.